IWASAKI Hiromichi

J-GLOBAL         Last updated: Jul 8, 2019 at 15:17
IWASAKI Hiromichi
University of Fukui
Faculty of Medical Sciences
Job title
医学博士(Fukui University)

Research Areas



生化系, Graduate School, Division of Medicine, Fukui Medical School
医学科, Faculty of Medicine, Fukui Medical School

Published Papers

Yamada K, Shigemi H, Suzuki K, Yasutomi M, Iwasaki H, Ohshima Y
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy      Jun 2019   [Refereed]
Enomoto S, Shigemi H, Kitazaki Y, Ikawa M, Yamamura O, Hamano T, Tai K, Iwasaki H, Koizumi H, Hasegawa M, Takeda K, Nakamoto Y
Journal of the neurological sciences   399 169-171   Apr 2019   [Refereed]
Kobayashi A, Iwasaki H
The New England journal of medicine   380(10) e11   Mar 2019   [Refereed]
Ookura M, Hosono N, Tasaki T, Oiwa K, Fujita K, Ito K, Lee S, Matsuda Y, Morita M, Tai K, Negoro E, Kishi S, Iwasaki H, Ueda T, Yamauchi T
Medicine   97(44) e12981   Nov 2018   [Refereed]
Kobayashi A, Iwasaki H
IDCases   9 8   2017   [Refereed]


K.Inai, H.Iwasaki, S.Noriki, S.Ikegaya, M.Yamashita, Y.Imamura, N.Takimoto, H.Kato, T.Ueda, H.Naiki
Int J Hematol   86(3) 225-232   2007
岩崎 博道
福井県医師会だより   (555) 10   2007
主な真菌感染症 カンジダ症
岩崎 博道, 上田 孝典
血液フロンティア   17(9) 65-72   2007
Combined low-dose cytarabine, melphalan and mitoxantrone for older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome
T.Yamauchi, E.Negoro, H.Arai, S.Ikegaya, K.Takagi, H.Takemura, K.Inai, A.Yoshida, Y.Urasaki, H.Iwasaki, T.Ueda
Anticancer Res   27(4C) 2635-2639   2007
岩崎 博道, 木下 圭一, 上田 孝典
血液フロンティア   17(4) 105-111   2007

Books etc

Acari-borne diseases reviewed from a standpoint of clinical hematologist
Different doses of cytosine arabinoside in leukemia chemotherapy have different mechanism of action. (共著)
Recent Advances in Chemotherapy   1993   
Mechanism of action of SM5887, a new anthracycline agent, in HL60 cells. (共著)
Recent Advances in chemotherapy   1993   
A new diagnostic aid for deep mycosis associated with hematologic disease using(1→3)-β-D-glucan assay.
Recent Advances in Chemotherapy   1993   
Daunorubicin resistance in a K562-derived cell line and its reversal by Idarubicin(共著)
The Mecanism and New Approach on Drug Resistance of Cancer Cell   1993   

Conference Activities & Talks

Exploration of sepsis-confirming markers for hospital autopsy
IWASAKI Hiromichi
European Scientific Conference   18 Feb 2019   

Research Grants & Projects

Action mechanism of antileukemic agents in leukemia chemotherapy
Diagnosis of deep-seated fungal infection
Clinical study of rickettsial infection